Pages without language links

From QIBA Wiki
Jump to: navigation, search

The following pages do not link to other language versions.

Prefix  

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. 2009 Profile Template Sketch
  2. 2012 Call Summaries
  3. 2013 Call Summaries
  4. 2014 Call Summaries
  5. 2015 Call Summaries
  6. 2016 Call Summaries
  7. 2019
  8. 2020
  9. 2021
  10. AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Ctte
  11. AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte
  12. ARCHIVE
  13. ASFNR Materials - Abstract for Review
  14. Acquisition Protocols Technical Subcommittee
  15. Additional letters of support can be found here
  16. Agenda from 02.17.2012 FDG-PET Tech Committee Call
  17. Alzheimer's Disease PET Archive
  18. Ambition Levels for Collaboration
  19. Archive
  20. Archive - Initial Target Selection and Roadmap
  21. Archive - Lung Density
  22. Archive for Lung Nodule Assessment in CT Screening Draft Profiles
  23. Archive for previously known QIBA Modality Committees
  24. Archived: 2009 COPD/Asthma Call Summaries
  25. Archived: 2010 - 2011 fMRI Reproducibility Call Summaries
  26. Archived: 2010 COPD/Asthma Call Summaries
  27. Archived: 2011 COPD/Asthma Call Summaries
  28. Archived: 2011 CT Volumetry - Group 3A Call Summaries
  29. Archived: 2012 CT Volumetry - Group 3A Call Summaries
  30. Archived: 2012 QIBA US SWS Technical Committee call summaries
  31. Archived: 2012 fMRI Reproducibility Call Summaries
  32. Archived: 2013 fMRI Bias WG Call Summaries
  33. Archived: 2014 fMRI Bias WG Call Summaries
  34. Archived: 2016 Lung Density BC Call Summaries
  35. Archived: fMRI Bias WG Call Summaries
  36. Archived: fMRI Reproducibility Call Summaries
  37. Archived "What is a Profile?" description as of 08.19.2011
  38. Archived - 2010-2011 fMRI Reproducibility Call Summaries
  39. Archived - 2011 fMRI Reproducibility Call Summaries
  40. Archived DCE-MRI Profiles
  41. Archived Versions
  42. Archived Versions of QIBA Vol CT - Group 3A draft documents
  43. Assessment Procedure Guidance
  44. Atherosclerosis Biomarkers Profile Draft Archive
  45. Balloting Process
  46. Bobby test
  47. CEUS BC Call Summaries
  48. CEUS Task Force (TF) Call Summaries
  49. COPD Group Call Summaries
  50. CTV-AD Considerations for Future Editions
  51. CT Acquisition Protocol Groundwork
  52. CT Angiography Biomarker Ctte
  53. CT Angiography Call Summaries Archive
  54. CT Angiography Profile Draft Archive
  55. CT Coordinating Committee
  56. CT Draft Proffered Protocols
  57. CT Small Lung Nodule Biomarker Ctte
  58. CT Volumetry BC Call Summaries Archive
  59. CT Volumetry Biomarker Ctte
  60. Call Agenda Topics
  61. Call Summaries
  62. Call Summaries Archive
  63. Catalog
  64. Change Tracking and File Naming
  65. Claim Confirmation Process
  66. Claim Guidance
  67. Claim Language/Detail
  68. Clinical Applications and Biological Targets Subcommittee
  69. Clinical Sites
  70. Clinical Trial Planning
  71. Clinical Trials Collaboration
  72. Columbia University Medical Center
  73. Combined: System Dependencies & Phantom Development Subcommittees
  74. Combined Nuclear Medicine Biomarker Committee Call Summaries
  75. Comment Resolutions
  76. Committee Organization
  77. Committee Procedures
  78. Committee Sunset Process
  79. Committee Template
  80. Committee on Image Archives
  81. Committee on Open Image Archives
  82. Committees
  83. Communications Committee
  84. Conformity Assessment
  85. Consensus Process
  86. Consensus Protocols
  87. CoreLab Partners, Inc.
  88. CoreLab Partners, Inc., Round-2
  89. Covariates Rationale
  90. DCE-MRI BC Call Summaries Archive
  91. DCE-MRI Project Page
  92. DCE MRI Biomarker Ctte
  93. DSC-MRI Call Summaries Archive
  94. DSC MRI Biomarker Ctte
  95. DTI MRI Biomarker Ctte
  96. DWI Literature Review
  97. DWI MR BC Call Summaries Archive
  98. DWI MR Biomarker Ctte
  99. DWI Profile Development Archive
  100. DWI Profile Draft Archive
  101. Dana-Farber Cancer Institute
  102. David Geffen School of Medicine at UCLA, Department of Radiology
  103. David Geffen School of Medicine at UCLA, Department of Radiology,Round-2
  104. Dept of Research Scatch Page
  105. Digital Reference Objects-Images
  106. Document Archive
  107. Documents / Call Summaries
  108. Dr Tucker's New Test Page
  109. Draft Consensus Protocols
  110. Draft New Main Page
  111. Draft Proffered Protocols
  112. Duke Brain Imaging and Analysis Center
  113. Duke University
  114. Duke University Medical Center
  115. EIBIR/QIBA ASL Biomarker Ctte
  116. Education
  117. Example Use Case for Open Image Archives
  118. Example Use Case for Open Image archives
  119. Executive Committee
  120. Executive Committee Call Summaries Archive
  121. FDG-PET/CT UPICT Template - (Editable)
  122. FDG-PET Archive
  123. FDG-PET Biomarker Ctte
  124. FDG-PET CT Template
  125. FDG-PET Call Summaries Archive
  126. FDG-PET Reference Material
  127. FMRI
  128. FMRI-DICOM WG Call Summaries
  129. FMRI Biomarker Ctte
  130. FMRI Call Summaries
  131. FMRI Call Summaries Archive
  132. FMRI Project Page
  133. FMRI Working Documents Archive
  134. FMRI moc profile
  135. Fmri PubMed search
  136. Follow-up Editorial
  137. Fused Images
  138. Ground Truth Strategy
  139. Groundwork and Profiling
  140. Group 3A Call Summaries Archive
  141. Guidance Document Process
  142. How To's
  143. How to Create a Google Doc
  144. How to Upload Documents to the UPICT Library
  145. How to Write a Profile
  146. How to use QIBA Profiles
  147. I-123 Biomarker Committee
  148. Industry
  149. Initial Target Selection
  150. Invitation to Participate
  151. Joe's test
  152. Johns Hopkins Univ School of Medicine
  153. Johns Hopkins University School of Medicine
  154. Johns Hopkins University School of Medicine, Round-2
  155. Julie's COPD archive
  156. Julie's test
  157. Julie's test page
  158. Lesion Sizing Toolkit
  159. List of Certified Conformant Users (QIBA Tested)
  160. List of Registered Conformant Users (Self-attestation
  161. List of Registered Conformant Users (Self-attestation)
  162. Lung Density/COPD BC Call Summaries Archive
  163. Lung Density BC Call Summaries
  164. Lung Density Biomarker Ctte
  165. Lung Nodule Assessment in CT Screening Call Summary Archive
  166. MRE BC Call Summaries Archive
  167. MRE Biomarker Committee Call Summaries
  168. MRE Biomarker Ctte
  169. MR Acquisition Protocols
  170. MR Archive
  171. MR Coordinating Committee
  172. MR Draft Proffered Protocols
  173. MSK Biomarker Committee Call Summaries
  174. MSK Biomarker Committee Call Summaries Archive
  175. MSK Biomarker Ctte
  176. Main Page
  177. Maintenance Process
  178. Medical College of Wisconsin
  179. Metrology Committee
  180. Metrology Committee Call Summaries Archive
  181. Moc-up page
  182. Moc technical committee
  183. Modality Committee Archive
  184. Monthly FDG-PET Call Summaries
  185. Myocardial Blood Flow Biomarker Committee
  186. NIST
  187. NM Coordinating Committee
  188. New Protocol Here
  189. Normalization Process
  190. Orphan Documents
  191. PDFF Biomarker Committee Call Summaries
  192. PDFF Biomarker Committee Call Summaries Archive
  193. PDFF Biomarker Ctte
  194. PDF BC Call Summaries Archive
  195. PET Amyloid BC Call Summaries Archive
  196. PET Amyloid Biomarker Ctte
  197. PET Myocardial Blood Flow Biomarker Committee
  198. PET Myocardial Blood Flow Call Summaries
  199. PUBLIC COMMENT WORK PAGE
  200. Perfusion, Diffusion and Flow-MRI Biomarker Ctte
  201. Perlman Advisory Group
  202. Phantom Development
  203. Phantom Development Subcommittee
  204. Phantom Development Technical Subcommittee
  205. Phantom Protocol & Data Analysis
  206. Phantoms And Tests Subcommittee
  207. Pharma Imaging Network for Therapeutics and Diagnostics (PINTAD)
  208. Pilot Conformance Projects Under Development
  209. Process
  210. Process Committee Call Summaries
  211. Process Committee Call Summaries Archive
  212. Process Coordinating Committee
  213. Proffered Protocols
  214. Profile: CT Lung Nodule - Small Nodule in Neoadjuvant Setting
  215. Profile: CT Lung Nodule - Small Nodule in neoadjuvant Setting
  216. Profile: CT Lung Nodule Response
  217. Profile: CT Lung Nodule Volume Change for Primary, Hilar and Medistinal Lymph Nodes
  218. Profile: CT Lung Nodule Volume Measurement for Primary/Regional Nodes and Metastatic Sites
  219. Profile: FDG-PET Whole Body
  220. Profile Conformance
  221. Profile Development
  222. Profile Editions
  223. Profile Strategy for Vol CT
  224. Profile Writing Guidelines
  225. Profile drafts
  226. Profiles
  227. Project (19a): Validation of Breath Hold Task for Assessment of Cerebrovascular Responsiveness and Calibration of Language Activation Maps to Optimize Reproducibility
  228. Project 1a: Inter-scanner/ Inter-clinic Comparison of Reader Nodule Sizing in CT Imaging of a Phantom
  229. Project 2a: Assessing Measurement Variability of Lung Lesions in Patient Data Sets
  230. Project 2a: Assessing Measurement Variability of Lung Lsions in Patient Data Sets
  231. Projects
  232. Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson
  233. Public Comment Process
  234. Publication Process
  235. Pulse-Echo Quantitative Ultrasound (PEQUS) Call Summaries
  236. QIBA/RIC ctte
  237. QIBA / QuIC-ConCePT Call Summaries
  238. QIBA Artificial Data Evaluation Software
  239. QIBA COPD/Asthma Committee
  240. QIBA Collaborations
  241. QIBA Concepts
  242. QIBA DCE-MRI Technical Committee Call Summaries
  243. QIBA FDG-PET/CT SUV Subcommittee Site
  244. QIBA Informational Meeting (Dec 1st at RSNA 2008) - Slide Content Review
  245. QIBA Kiosk Content Review
  246. QIBA Leadership Reference Materials
  247. QIBA Leadership Slides
  248. QIBA Modality Committees
  249. QIBA News
  250. QIBA Newsletter Archive

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)